IGC Pharma, Inc.
IGCAMEX
Healthcare
Biotechnology
$0.27
-0.01(-1.8%)
52W $0.25 – $0.47
Quick:
8-K
Mar 30, 2026 (1 weeks ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Mar 12, 2026 (3 weeks ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jan 6, 2026 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jan 2, 2026 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Dec 15, 2025 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Nov 14, 2025 (4 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Nov 14, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Oct 14, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Oct 1, 2025 (6 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Aug 14, 2025 (7 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
10-K
Jun 27, 2025 (9 months ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
8-K
Jun 17, 2025 (9 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Feb 14, 2025 (1 years ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
10-Q
Nov 12, 2024 (1 years ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Sep 27, 2024 (1 years ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Aug 27, 2024 (1 years ago)Current Report
Material event disclosure
Event materiality and market reaction
SC 13D/A
Aug 14, 2024 (1 years ago)Beneficial Ownership (Active) (Amendment)
Activist investor position disclosure
Stated intentions, proposed changes
10-Q
Aug 7, 2024 (1 years ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Aug 2, 2024 (1 years ago)Current Report
Material event disclosure
Event materiality and market reaction
10-K
Jun 24, 2024 (1 years ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures